Inhibition of transcription, expression, and secretion of the vascular epithelial growth factor in human epithelial endometriotic cells by romidepsin

Fertility and Sterility

Volumn 95, Issue 5, 2011, Pages 1579-1583

  Imesch, Patrick ^a   Samartzis, Eleftherios P ^a   Schneider, Michael ^a   Fink, Daniel ^a   Fedier, André ^a  

^a UNIVERSITÄTSSPITAL ZÜRICH   (Switzerland)

Author keywords

Endometriosis; HIF 1 ; human epithelial endometriotic cells; romidepsin; VEGF expression and secretion

Indexed keywords

COBALT CHLORIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; ROMIDEPSIN; VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOMETRIOSIS; ENDOMETRIUM CELL; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANGIOGENESIS INHIBITORS; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TRANSFORMED; DEPSIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG EVALUATION, PRECLINICAL; ENDOMETRIOSIS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOVASCULARIZATION, PATHOLOGIC; PERITONEAL DISEASES; TRANSCRIPTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79952987900     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2010.12.058     Document Type: Article

References (33)

1. L.C. Giudice, and L.C. Kao Endometriosis Lancet 364 2004 1789 1799 (Pubitemid 39488065)
2. K.J. Berkley, A.J. Rapkin, and R.E. Papka The pains of endometriosis Science 308 2005 1587 1589 (Pubitemid 40807498)
3. C. Farquhar Endometriosis Bmj 334 2007 249 253 (Pubitemid 46225604)
4. J.A. Sampson Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity Am J Obstet Gynecol 14 1927 442 469
5. S.W. Guo Epigenetics of endometriosis Mol Hum Reprod 15 2009 587 607
6. D.W. Leung, G. Cachianes, W.J. Kuang, D.V. Goeddel, and N. Ferrara Vascular endothelial growth factor is a secreted angiogenic mitogen Science 246 1989 1306 1309 (Pubitemid 20066716)
7. R.N. Taylor, D.I. Lebovic, and M.D. Mueller Angiogenic factors in endometriosis Ann NY Acad Sci 955 2002 89 100 118, 396-406 (Pubitemid 34271066)
8. J. McLaren, A. Prentice, D.S. Charnock-Jones, and S.K. Smith Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis Hum Reprod 11 1996 220 223 (Pubitemid 26047702)
9. M.D. Mueller, D.I. Lebovic, E. Garrett, and R.N. Taylor Neutrophils infiltrating the endometrium express vascular endothelial growth factor: potential role in endometrial angiogenesis Fertil Steril 74 2000 107 112 (Pubitemid 30427282)
10. J.L. Shifren, J.F. Tseng, C.J. Zaloudek, I.P. Ryan, Y.G. Meng, and N. Ferrara Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis J Clin Endocrinol Metab 81 1996 3112 3118 (Pubitemid 26323917)
11. J. Donnez, P. Smoes, S. Gillerot, F. Casanas-Roux, and M. Nisolle Vascular endothelial growth factor (VEGF) in endometriosis Hum Reprod 13 1998 1686 1690 (Pubitemid 28310515)
12. R.N. Taylor, and M.D. Mueller Anti-angiogenic treatment of endometriosis: biochemical aspects Gynecol Obstet Invest 57 2004 54 56 (Pubitemid 38186438)
13. S.P. Tabruyn, and A.W. Griffioen Molecular pathways of angiogenesis inhibition Biochem Biophys Res Commun 355 2007 1 5 (Pubitemid 46273381)
14. A. Villar-Garea, and M. Esteller Histone deacetylase inhibitors: understanding a new wave of anticancer agents Int J Cancer 112 2004 171 178 (Pubitemid 39244355)
15. S. Minucci, and P.G. Pelicci Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer Nat Rev Cancer 6 2006 38 51 (Pubitemid 43054973)
16. P. Imesch, D. Fink, and A. Fedier Romidepsin reduces histone deacetylase activity, induces acetylation of histones, inhibits proliferation, and activates apoptosis in immortalized epithelial endometriotic cells Fertil Steril 94 2010 2838 2842
17. P.A. Konstantinopoulos, G.P. Vandoros, and A.G. Papavassiliou FK228 (depsipeptide): a HDAC inhibitor with pleiotropic antitumor activities Cancer Chemother Pharmacol 58 2006 711 715 (Pubitemid 44167398)
18. J.C. Byrd, G. Marcucci, M.R. Parthun, J.J. Xiao, R.B. Klisovic, and M. Moran A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia Blood 105 2005 959 967 (Pubitemid 40170861)
19. R.P. Whitehead, C. Rankin, P.M. Hoff, P.J. Gold, K.G. Billingsley, and R.A. Chapman Phase II trial of Romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336) Invest New Drugs 27 2008 469 475
20. H.J. Kwon, M.S. Kim, M.J. Kim, H. Nakajima, and K.W. Kim Histone deacetylase inhibitor FK228 inhibits tumor angiogenesis Int J Cancer 97 2002 290 296 (Pubitemid 34049018)
21. Y. Sasakawa, Y. Naoe, T. Noto, T. Inoue, T. Sasakawa, and M. Matsuo Antitumor efficacy of FK228, a novel histone deacetylase inhibitor, depends on the effect on expression of angiogenesis factors Biochem Pharmacol 66 2003 897 906 (Pubitemid 37083586)
22. A. Zeitvogel, R. Baumann, and A. Starzinski-Powitz Identification of an invasive, N-cadherin-expressing epithelial cell type in endometriosis using a new cell culture model Am J Pathol 159 2001 1839 1852 (Pubitemid 33062526)
23. S.K. Banu, J. Lee, A. Starzinski-Powitz, and J.A. Arosh Gene expression profiles and functional characterization of human immortalized endometriotic epithelial and stromal cells Fertil Steril 90 2008 972 987
24. W.G. An, M. Kanekal, M.C. Simon, E. Maltepe, M.V. Blagosklonny, and L.M. Neckers Stabilization of wild-type p53 by hypoxia-inducible factor 1α Nature 392 1998 405 408
25. L. Ellis, H. Hammers, and R. Pili Targeting tumor angiogenesis with histone deacetylase inhibitors Cancer Lett 280 2009 145 153
26. V. Bourlev, N. Volkov, S. Pavlovitch, N. Lets, A. Larsson, and M. Olovsson The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions Reproduction 132 2006 501 509 (Pubitemid 44524514)
27. A. Beliard, A. Noël, F. Goffin, F. Frankenne, and J.M. Foidart Role of endocrine status and cell type in adhesion of human endometrial cells to the peritoneum in nude mice Fertil Steril 78 2002 973 978 (Pubitemid 35292496)
28. A.W. Nap, P.G. Groothuis, A.Y. Demir, J.W. Maas, G.A. Dunselman, and A.F. de Goeij Tissue integrity is essential for ectopic implantation of human endometrium in the chicken chorioallantoic membrane Hum Reprod 18 2003 30 34 (Pubitemid 36138848)
29. H. Manabe, Y. Nasu, T. Komiyama, T. Furumatsu, A. Kitamura, and S. Miyazawa Inhibition of histone deacetylase down-regulates the expression of hypoxia-induced vascular endothelial growth factor by rheumatoid synovial fibroblasts Inflamm Res 57 2008 4 10
30. M.H. Wu, K.F. Chen, S.C. Lin, C.W. Lgu, and S.J. Tsai Aberrant expression of leptin in human endometriotic stromal cells is induced by elevated levels of hypoxia inducible factor-1α Am J Pathol 170 2007 590 598
31. S.H. Kim, J.W. Jeong, J.A. Park, J.W. Lee, J.H. Seo, and B.K. Jung Regulation of the HIF-1α stability by histone deacetylases Oncol Rep 17 2007 647 651
32. Y. Mie Lee, S.H. Kim, H.S. Kim, M. Jin Son, H. Nakajima, and H. Jeong Kwon Inhibition of hypoxia-induced angiogenesis by FK228, a specific histone deacetylase inhibitor, via suppression of HIF-1α activity Biochem Biophys Res Commun 300 2003 241 246 (Pubitemid 36042959)
33. Q.C. Yang, B.F. Zeng, Z.M. Shi, Y. Dong, Z.M. Jiang, and J. Huang Inhibition of hypoxia-induced angiogenesis by trichostatin A via suppression of HIF-1a activity in human osteosarcoma J Exp Clin Cancer Res 25 2006 593 599 (Pubitemid 46170683)